Skip to main content

Marta Villalba Montaner

Institutions of which they are part

Predoctoral researcher
Vall Hebron Institut de Recerca
Marta  Villalba  Montaner

Projects

CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY RELATED MALIGNANCIES

IP: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Collaborators: Marta Villalba Montaner, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Bárbara Tazón Vega, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY, Silvia Saumell Tutusaus, CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL IN CANCER PATIENTS: IMPACT ON IMMUNE DYSFUNCTION, TREATMENT RESPONSE AND THERAPY
Funding agency: Instituto de Salud Carlos III
Funding: 215380
Reference: PI20/00881
Duration: 01/01/2021 - 31/12/2023

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.